The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
α2-Adrenergic Agonists for Regional Anesthesia: A Clinical Review of Clonidine (1984 - 1995)
Abstract
(Eisenach) Professor and Chair for Anesthesia Research, Wake Forest University Medical Center, Winston-Salem, North Carolina.(De Kock) Staff Anesthesiologist, Service d'Anesthesiologie, Universite Catholique de Louvain, Brussels, Belgium.(Klimscha) Staff Anesthesiologist, University of Vienna, Vienna, Austria.From the Department of Anesthesia, Wake Forest University Medical Center, Winston-Salem, North Carolina, and Universite Catholique de Louvain, Brussels, Belgium. Submitted for publication January 26, 1996. Accepted for publication May 10, 1996. Supported in part by National Institutes of Health grants GM35523 and GM48085. Dr. Eisenach is a consultant to Fujisawa, USA, which is developing clonidine for epidural use in the United States, and Abbott Laboratories, which is developing dexmedetomidine for intravenous use in the United States.Address reprint requests to Dr. Eisenach: Department of Anesthesia, Wake Forest University Medical Center, Medical Center Boulevard, Winston-Salem, North Carolina 27157-1009. Address electronic mail to: eisenach@bgsm.edu.Key words: Alpha2-adrenergic agonists, clonidine. Anesthetic techniques; epidural; spinal. Pain.Alpha2-ADRENERGIC mechanisms of analgesia have been exploited for more than 100 yr. Cocaine, the first spinal anesthetic, produces analgesia primarily by its local anesthetic action, but also inhibits norepinephrine re-uptake, and spinal cocaine produces analgesia, in part, by enhancing noradrenergic stimulation of alpha2-adrenoceptors. [1]Near the turn of the century, epinephrine was shown to produce spinal analgesia in animals, [2]an effect now recognized to be secondary to alpha2-adrenoceptor stimulation. [3,4]Nearly 50 yr ago, spinal epinephrine alone was shown to produce clinically useful analgesia, [5]although it is most commonly combined with local anesthetics for this purpose.Veterinarians have used alpha2-adrenergic agonists (xylazine, detomidine, medetomidine) for many years for regional analgesia, but experience with these agents in humans dates back only slightly more than 10 yr. In 1984, Tamsen and Gordh, [7]after testing for neurotoxicity in animals, [6]injected a parenteral preparation of the alpha2-adrenergic agonist, clonidine, epidurally in two patients with chronic pain. Since then, a complete toxicologic assessment (effects on spinal cord blood flow, [8-10]behavior after lumbar and cervical intrathecal injection in sheep and monkeys, [11,12]and histopathology in sheep, rats, and dogs [11,13,14]) has suggested that clonidine is safe for intraspinal use, and the vast majority of publications examining injectable clonidine for analgesia come from Europe, using their commercially available preparation. In the United States, a preservative-free preparation of clonidine has been submitted to the Food and Drug Administration for approval under the orphan drug indication of epidural treatment for intractable cancer pain.The goal of this review is to provide a clinically useful synthesis of published experience with clonidine for regional anesthesia, focusing on efficacy when administered alone and in combination with other analgesics in specific patient populations and appropriate monitoring and treatment of side effects. A reasonably comprehensive review of publications through 1995 includes 2,116 patients treated with clonidine via epidural, intrathecal, or peripheral injection (Table 1). Neuraxial administration reports consist primarily of single or multiple boluses for < 24 h (1,437 patients, 77% of total), followed by brief (< 48 h) continuous infusion (270 patients, 15% of total). Prolonged epidural infusion for > 1 week in the treatment of chronic pain represents 148 patients, only 8% of the total.Alpha2-Adrenoceptors are located on primary afferent terminals (both at peripheral and spinal endings), on neurons in the superficial laminae of the spinal cord, and within several brainstem nuclei implicated in analgesia, [15]supporting the possibility of analgesic action at peripheral, spinal, and brainstem sites. Experimental work in animals supports analgesic actions of alpha2-adrenergic agonists at all three sites, although their relative importance is controversial. Notably lacking are alpha2-adrenoceptors on axons of peripheral nerves. Clonidine does produce a minor degree of nerve conduction blockade at high concentrations, however, with some preference for C-fibers. [16-18]This conduction blockade may underlie, in part, the enhancement of peripheral nerve block when this agent is added to local anesthetics (see below).Several lines of evidence support a spinal action of clonidine in producing analgesia in humans. First, in a study in volunteers, [19]a single lumbar epidural bolus injection of clonidine produced analgesia in the lower, but not upper, extremity against a noxious cold stimulus, as would be anticipated from a spinal action. When clonidine was infused for 4 h in the lumbar epidural space in a subsequent study in volunteers, [2
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unnerstall, J. R., Kopajtic, T. A., & Kuhar, M. J. (1984) · Brain Research Reviews · doi:10.1016/0165-0173(84)90030-4 · Cited by 708
Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia.
Maze, M., & Tranquilli, W. J. (1991) · PubMed · Cited by 700
Epidural clonidine analgesia for intractable cancer pain
Eisenach, J. C., DuPen, S., Dubois, M., Miguel, R., & Allin, D. (1995) · Pain · doi:10.1016/0304-3959(94)00209-w · Cited by 533
Self-citationYaksh, T. L., & Ramana Reddy, S. V. (1981) · Anesthesiology · doi:10.1097/00000542-198106000-00004 · Cited by 516
Spinal cord pharmacology of adrenergic agonist-mediated antinociception.
Reddy, S. V., Maderdrut, J. L., & Yaksh, T. L. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32101-4 · Cited by 434
Jahangiri, M., Jayatunga, A., Bradley, J. W., et al. (1994) · PubMed · Cited by 225
Hemodynamic and Analgesic Actions of Epidurally Administered Clonidine
Eisenach, J., Detweiler, D., & Hood, D. (1993) · Anesthesiology · doi:10.1097/00000542-199302000-00011 · Cited by 221
Self-citationEpidural Clonidine Treatment for Refractory Reflex Sympathetic Dystrophy
Rauch, R. L., Eisenach, J. C., Jackson, K., Young, L. D., Southern, J., & Yaksh, T. L. (1993) · Anesthesiology · doi:10.1097/00000542-199312000-00001 · Cited by 206
Self-citationButterworth, J. F. I., & Strichartz, G. R. (1993) · PubMed · Cited by 199
A Comparison of Intrathecal, Epidural, and Intravenous Sufentanil for Labor Analgesia
Camann, W. R., Denney, R. A., Holby, E. D., & Datta, S. (1992) · Anesthesiology · doi:10.1097/00000542-199211000-00008 · Cited by 188
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777229 · Cited by 764
Spinal cord mechanisms of pain
D’Mello, R., & Dickenson, A. H. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen088 · Cited by 640
Pertovaara, A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.001 · Cited by 597
Persistent Postsurgical Pain: Pathophysiology and Preventative Pharmacologic Considerations
Richebé, P., Capdevila, X., & Rivat, C. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002238 · Cited by 439
Metadata
- Authors
- Eisenach, J. C., De Kock, M., & Klimscha, W.
- Venue
- Anesthesiology
- Published
- 1996-09-01
- Volume
- 85
- Issue
- 3
- Pages
- 655-674.
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W1999776567
- Cited by
- 888
- References
- 40
- FWCI
- 26.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: α2-Adrenergic Agonists for Regional Anesthesia: A Clinical Review of Clonidine (1984 - 1995). https://app.cochat.ai/papers/10.1097/00000542-199609000-00026
- The paper
- Eisenach, J. C., De Kock, M., & Klimscha, W. (1996). α2-Adrenergic Agonists for Regional Anesthesia: A Clinical Review of Clonidine (1984 - 1995). Anesthesiology. https://doi.org/10.1097/00000542-199609000-00026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.